Trial Profile
Phase I study of extended release bupivacaine/meloxicam [HTX 011] in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2015
Price :
$35
*
At a glance
- Drugs Bupivacaine/meloxicam (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- Sponsors Heron Therapeutics
- 19 Mar 2015 Results published in a Heron Therapeutics media release.
- 11 Feb 2015 This trial has been initiated and initial results are expected before the end of the first quarter of 2015, according to a Heron Therapeutics media release.
- 11 Feb 2015 Status changed from planning to recruiting, according to a Heron Therapeutics media release.